Mirvie Announces Results from Largest Molecular Study in Pregnancy and Clinical Validation of Simple Blood Test to Predict Risk for Preeclampsia Months Before Symptoms
Landmark research published in Nature Communications advances the biological understanding of hypertensive disorders of pregnancy, unlocking the potential for personalized... Read more.
Flux Power Provides Update on Major Orders from Leading Airlines, Signaling Continued Industry-Wide Shift to Sustainable GSE Solutions
Orders Reflecting Growing Trend of New Airline Customers Totaled over $6 Million in the Last Calendar Year with Additional Orders Expected Throughout 2025 VISTA,... Read more.
Cyberattacks are Fewer in Number but Smarter in Strategy, Says CDW Canada Study
Amid increasingly effective cyberattacks, Canadian organizations experience an average downtime of 14 days, disrupting essential day-to-day business operations TORONTO–(BUSINESS... Read more.
FLIR Introduces FLIR MIX™: A Breakthrough in Multispectral Infrared Imaging
A new era of infrared research is here: FLIR MIX Starter Kits synchronize and align high-speed thermal and visible imagery with precision, delivering clearer insights... Read more.
Omnitron Sensors Appoints Ijaz Jafri as Vice President of Engineering to Drive Product Commercialization
— Distinguished engineering executive and technologist to lead Omnitron’s product development and manufacturing scale-up LOS ANGELES–(BUSINESS WIRE)–#MEMS—Omnitron... Read more.
Pathward Releases 2024 Sustainability Report
Report highlights ongoing efforts to power financial inclusion through sustainable governance and practices. SIOUX FALLS, S.D.–(BUSINESS WIRE)–Pathward®,... Read more.
Karrier One and AT&T Expands Global Wi-Fi Offload Coverage and Advance Decentralized Connectivity
MIAMI–(BUSINESS WIRE)–$DEPIN #Blockchain–Karrier One Inc., a leader in Web3-powered telecom solutions, has signed an agreement with AT&T Mobility... Read more.
Atalanta Therapeutics Publishes Preclinical Data Supporting Investigational RNAi Therapy for KCNT1-Related Epilepsy
– Single dose of di-siRNA ATL-201 produced near-complete seizure suppression through 6 months of observation in mouse model – Data support continued advancement... Read more.
Rallybio to Discontinue Development of RLYB212 for Prevention of FNAIT
– RLYB212 Phase 2 PK Results Did Not Achieve Target Concentrations, Including Minimum Target Concentration Required for Efficacy – – RLYB116 Confirmatory PK/PD... Read more.
Pantheon Raises $5.2 Billion for Third Senior Credit Secondaries Program
Capital raise cements the firm’s leadership position in the global private credit secondaries solutions market Success driven by broad support from institutional... Read more.